Torrent Pharmaceuticals Limited has officially submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. This submission, made on June 1, 2026, aligns with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report, which includes an Independent Reasonable and Limited Assurance Report from Grant Thornton Bharat LLP, is a part of the company’s Annual Report and is also available on their website.
Company Submits Key Sustainability Report
Torrent Pharmaceuticals Limited announced on June 1, 2026, the submission of its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. This crucial filing fulfills the requirements of Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Assurance and Accessibility
The submitted BRSR is accompanied by an Independent Reasonable and Limited Assurance Report provided by Grant Thornton Bharat LLP. This assurance underlines the credibility and reliability of the disclosed sustainability information. The company has ensured that the BRSR is an integral part of its Annual Report for the financial year 2025-26 and is readily accessible to all stakeholders on its official website, www.torrentpharma.com.
Commitment to Transparency
This proactive submission highlights Torrent Pharmaceuticals’ commitment to transparency and robust corporate governance. The BRSR aims to provide a comprehensive overview of the company’s performance and progress against its environmental, social, and governance (ESG) objectives, demonstrating a dedication to responsible business practices and sustainable development.
Source: BSE
